Loss of NARS1 impairs progenitor proliferation in cortical brain organoids and leads to microcephaly.
Lu WangZhen LiDavid SievertDesirée E C SmithMarisa I MendesDillon Y ChenValentina StanleyShereen GhoshYulu WangMajdi KaraAyca Dilruba AslangerRasim O RostiHenry HouldenGajja S SalomonsJoseph G GleesonPublished in: Nature communications (2020)
Asparaginyl-tRNA synthetase1 (NARS1) is a member of the ubiquitously expressed cytoplasmic Class IIa family of tRNA synthetases required for protein translation. Here, we identify biallelic missense and frameshift mutations in NARS1 in seven patients from three unrelated families with microcephaly and neurodevelopmental delay. Patient cells show reduced NARS1 protein, impaired NARS1 activity and impaired global protein synthesis. Cortical brain organoid modeling shows reduced proliferation of radial glial cells (RGCs), leading to smaller organoids characteristic of microcephaly. Single-cell analysis reveals altered constituents of both astrocytic and RGC lineages, suggesting a requirement for NARS1 in RGC proliferation. Our findings demonstrate that NARS1 is required to meet protein synthetic needs and to support RGC proliferation in human brain development.
Keyphrases
- intellectual disability
- signaling pathway
- zika virus
- induced apoptosis
- cell cycle arrest
- single cell
- autism spectrum disorder
- protein protein
- ejection fraction
- white matter
- resting state
- amino acid
- endoplasmic reticulum stress
- binding protein
- newly diagnosed
- rna seq
- prognostic factors
- oxidative stress
- cell death
- functional connectivity
- neuropathic pain
- spinal cord
- patient reported outcomes
- brain injury
- cord blood
- ultrasound guided
- induced pluripotent stem cells